Przegląd Dermatologiczny (Nov 2014)

Treatment of psoriasis vulgaris: guidelines of experts of the Polish Dermatological Society. Part II: moderate to severe psoriasis

  • Jacek Szepietowski,
  • Zygmunt Adamski,
  • Grażyna Chodorowska,
  • Andrzej Kaszuba,
  • Waldemar Placek,
  • Lidia Rudnicka,
  • Adam Reich

DOI
https://doi.org/10.5114/dr.2014.46947
Journal volume & issue
Vol. 101, no. 6
pp. 455 – 472

Abstract

Read online

Psoriasis is a chronic inflammatory skin disease affecting about 1–3% of the general population. Recent years have seen great development in the treatment of this dermatosis, especially regarding moderate to severe psoriasis. More numerous and more widely available systemic therapies raise new challenges for all physicians treating patients with psoriasis. New questions arise about patients’ follow-up and long-term safety of such therapies. To meet the expectations of Polish dermatologists, we have prepared a second part of guidelines on the treatment of psoriasis, particularly concentrated on the therapy of severe forms of this disease. We hope that our suggestions will be valuable for physicians in their daily clinical practice. However, we would like to underline that every guideline is characterized by some vagueness, and the final decision about diagnosis and therapy should always be made individually for every patient based on the patient’s current clinical status and the most up-to-date scientific literature data.

Keywords